Quidel Lyra™ Direct HSV 1+2/VZV
|CE-IVD and IVD labeled|
|Genital herpes is misdiagnosed 20% of the time1|
|In the US, 16% of adults are HSV-2 seropositive, but only 10–25% of persons with HSV-2 infection have recognized genital herpes. Moreover, most HSV-2 infections are acquired from persons without a clinical history of genital herpes1|
|Early identification can help reduce transmission and suppress reactivation2|
|Plans can be made to avoid transmission to neonates|
|Quidel® Lyra™ Direct HSV 1+2/VZV Assay
(For sale in the US and Europe only. The assay is validated for use on the QuantStudio® Dx and the Applied Biosystems® 7500 Fast Dx Real-Time Instruments.)
|Quidel Lyra™ HSV/VZV External Controls||10 reactions||4481484|
For In Vitro Diagnostic Use.
- Hook, Edward W. III. 2012. “A New Look at Genital Herpes: The Critical Role of the Laboratory in Diagnosis and Management.” Medical Laboratory Observer 2012 July 44(7):8-12.
- Emmert, David. 2000. “Treatment of Common Cutaneous Herpes Simplex Virus Infections”. Am Fam Physician 2000 Mar 15;61(6):1697-1704..